Publications by authors named "Florence Loiseau"

Claim this Profile
E
Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.
Nicholas E Clifton, Nadège Morisot, Sylvie Girardon, Mark J Millan, Florence Loiseau

Psychopharmacology (Berl)· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia.
Julie Meffre, Séverine Chaumont-Dubel, Clotilde Mannoury la Cour, Florence Loiseau, David J G Watson

EMBO Mol Med· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
Anne Dekeyne, Mauricette Brocco, Florence Loiseau, Alain Gobert, Jean-Michel Rivet

J Pharmacol Exp Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex.
David J G Watson, Florence Loiseau, Manuela Ingallinesi, Mark J Millan, Charles A Marsden

Neuropsychopharmacology· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures.
Mark J Millan, Jerry J Buccafusco, Florence Loiseau, David J G Watson, Emmanuel Decamp

Int J Neuropsychopharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists.
Florence Loiseau, Mark J Millan

Eur Neuropsychopharmacol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
Mark J Millan, Florence Loiseau, Anne Dekeyne, Alain Gobert, Gunnar Flik

J Pharmacol Exp Ther· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex.
Florence Loiseau, Anne Dekeyne, Mark J Millan

Psychopharmacology (Berl)· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of melatonin and agomelatine in anxiety-related procedures in rats: interaction with diazepam.
Florence Loiseau, Claudine Le Bihan, Michel Hamon, Marie-Hélène Thiébot

Eur Neuropsychopharmacol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidepressant-like effects of agomelatine, melatonin and the NK1 receptor antagonist GR205171 in impulsive-related behaviour in rats.
Florence Loiseau, Claudine Le Bihan, Michel Hamon, Marie-Hélène Thiébot

Psychopharmacology (Berl)· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis